FDA Proposes Withdrawal of Low Blood Pressure Drug
FDA Proposes Withdrawal of Low Blood Pressure Drug
The U.S. Food and Drug Administration today proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the drug have not been done.
Aug 16, 2010
Latest in Home
NAM Opposes New Overtime, Noncompete Rules
April 24, 2024
Tesla 1Q Profit Falls 55%
April 24, 2024
Boeing Posts $355 Million Loss
April 24, 2024